|
Sign In to gain access to subscriptions and/or personal tools.
|
Book Review: Bridging Areas of Injury in the Spinal Cord
Mary Bartlett Bunge
The Miami Project to Cure Paralysis, University of Miami School of Medicine, mbunge{at}miami.edu
There is a devastating loss of function when substantial numbers of axons are interrupted by injury to the spinal cord. This loss may be eventually reversed by providing bridging prostheses that will enable axons to regrow across the injury site and enter the spinal cord beyond. This review addresses the bridging strategies that are being developed in a number of spinal cord lesion models: complete and partial transection and cavities arising from contusion. Bridges containing peripheral nerve, Schwann cells, olfactory ensheathing glia, fetal tissue, stem cells/neuronal precursor cells, and macrophages are being evaluated as is the administration of neurotrophic factors, administered by infusion or secreted by genetically engineered cells. Biomaterials may be an important factor in developing successful strategies. Due to the complexity of the sequelae following spinal cord injury, no one strategy will be effective. The compelling question today is: What combinations of the strategies discussed, or new ones, along with an initial neuroprotective treatment, will substantially improve outcome after spinal cord injury?
Key Words: Cellular bridges • CNS regeneration • CNS injury • Neurotrophins • Transplantation
The Neuroscientist, Vol. 7, No. 4,
325-339 (2001)
DOI: 10.1177/107385840100700409
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
F.-J. Obermair, A. Schroter, and M. Thallmair
Endogenous Neural Progenitor Cells as Therapeutic Target After Spinal Cord Injury
Physiology,
October 1, 2008;
23(5):
296 - 304.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. M. Tysseling-Mattiace, V. Sahni, K. L. Niece, D. Birch, C. Czeisler, M. G. Fehlings, S. I. Stupp, and J. A. Kessler
Self-Assembling Nanofibers Inhibit Glial Scar Formation and Promote Axon Elongation after Spinal Cord Injury
J. Neurosci.,
April 2, 2008;
28(14):
3814 - 3823.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Liu, C.-H. Chau, H. Liu, B. R. Jang, X. Li, Y.-S. Chan, and D. K. Y. Shum
Upregulation of chondroitin 6-sulphotransferase-1 facilitates Schwann cell migration during axonal growth.
J. Cell Sci.,
March 1, 2006;
119(Pt 5):
933 - 942.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Boyd, J. Lee, V. Skihar, R. Doucette, and M. D. Kawaja
LacZ-expressing olfactory ensheathing cells do not associate with myelinated axons after implantation into the compressed spinal cord
PNAS,
February 17, 2004;
101(7):
2162 - 2166.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Ruitenberg, G. W. Plant, F. P. T. Hamers, J. Wortel, B. Blits, P. A. Dijkhuizen, W. H. Gispen, G. J. Boer, and J. Verhaagen
Ex Vivo Adenoviral Vector-Mediated Neurotrophin Gene Transfer to Olfactory Ensheathing Glia: Effects on Rubrospinal Tract Regeneration, Lesion Size, and Functional Recovery after Implantation in the Injured Rat Spinal Cord
J. Neurosci.,
August 6, 2003;
23(18):
7045 - 7058.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. E. Hulsebosch
RECENT ADVANCES IN PATHOPHYSIOLOGY AND TREATMENT OF SPINAL CORD INJURY
Advan Physiol Educ,
December 1, 2002;
26(4):
238 - 255.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Takami, M. Oudega, M. L. Bates, P. M. Wood, N. Kleitman, and M. B. Bunge
Schwann Cell But Not Olfactory Ensheathing Glia Transplants Improve Hindlimb Locomotor Performance in the Moderately Contused Adult Rat Thoracic Spinal Cord
J. Neurosci.,
August 1, 2002;
22(15):
6670 - 6681.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
